It's been a rough summer for marijuana stocks. Investors have lost faith in the sector amid sluggish sales trends, a lack of legislative progress in the US,...
With the negative sentiment surrounding the broader market and some negative news in the cannabis industry putting downward pressure on the pot market, the...
No matter the positive steps taken by the US cannabis multi-state operators (MSOs), the market has completely shunned the stocks. A prime example is iAnthus...
A key to investing is understanding the market impact of analyst calls whether bullish or bearish. In the case of Canopy Growth (CGC), the market initially...
Canopy Growth (CGC), Canada’s largest cannabis company, reported fiscal Q1 earnings on August 14, and the results were anything but growth-oriented. At the...
As U.S. multi-state operators (MSOs) await federal approval of cannabis, the companies will increasingly need creative ways to finance acquisitions and growth....
The U.S. cannabis multi-state operator (MSO) sector isn’t getting a lot of respect lately despite a group of stocks building a strong future. A prime example...
Extraction cannabis company MediPharm Labs (MEDIF) has been accelerating its upward growth trajectory at the right time, as Canada is poised to give the go...
A lot of the Canadian cannabis LPs shunned the U.S. for global markets and the riches of major stock exchanges. The plan hasn’t really played out as...
The cannabis sector has a projected market opportunity topping $200 billion, but the companies that focus on large specific niches such as CBD might provide...
